Fagron NV (FAGR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.167x

Based on the latest financial reports, Fagron NV (FAGR) has a cash flow conversion efficiency ratio of 0.167x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€93.07 Million ≈ $108.81 Million USD) by net assets (€556.26 Million ≈ $650.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Fagron NV (FAGR) net asset quality to measure how much of total assets are equity-financed.

Fagron NV - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Fagron NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Fagron NV cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Fagron NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fagron NV ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sonida Senior Living Inc NYSE:SNDA	-0.007x
Crompton Greaves Consumer Electricals Limited NSE:CROMPTON	0.011x
Beijing Cisri Gaona Materials Tech SHE:300034	-0.004x
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SHE:300357	0.032x
Banpu Public Company Limited BK:BANPU	0.016x
G2 Goldfields Inc. TO:GTWO	-0.003x
Ratnamani Metals & Tubes Limited NSE:RATNAMANI	0.176x
Cimpress plc F:3UF	0.036x

Annual Cash Flow Conversion Efficiency for Fagron NV (2004–2025)

The table below shows the annual cash flow conversion efficiency of Fagron NV from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see FAGR market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€556.26 Million ≈ $650.32 Million	€128.28 Million ≈ $149.97 Million	0.231x	+6.05%
2024-12-31	€505.36 Million ≈ $590.82 Million	€109.89 Million ≈ $128.48 Million	0.217x	-5.30%
2023-12-31	€467.63 Million ≈ $546.70 Million	€107.38 Million ≈ $125.54 Million	0.230x	-14.28%
2022-12-31	€408.63 Million ≈ $477.73 Million	€109.46 Million ≈ $127.97 Million	0.268x	+11.17%
2021-12-31	€325.47 Million ≈ $380.50 Million	€78.42 Million ≈ $91.68 Million	0.241x	-33.17%
2020-12-31	€257.82 Million ≈ $301.42 Million	€92.95 Million ≈ $108.67 Million	0.361x	+15.13%
2019-12-31	€246.44 Million ≈ $288.12 Million	€77.17 Million ≈ $90.23 Million	0.313x	-10.38%
2018-12-31	€209.72 Million ≈ $245.18 Million	€73.28 Million ≈ $85.67 Million	0.349x	-23.32%
2017-12-31	€184.88 Million ≈ $216.15 Million	€84.25 Million ≈ $98.49 Million	0.456x	+3.20%
2016-12-31	€152.87 Million ≈ $178.73 Million	€67.50 Million ≈ $78.92 Million	0.442x	+139.01%
2015-12-31	€-64.77 Million ≈ $-75.73 Million	€73.31 Million ≈ $85.71 Million	-1.132x	-274.67%
2014-12-31	€156.94 Million ≈ $183.48 Million	€101.70 Million ≈ $118.89 Million	0.648x	+59.40%
2013-12-31	€155.17 Million ≈ $181.41 Million	€63.08 Million ≈ $73.74 Million	0.407x	+47.25%
2012-12-31	€245.38 Million ≈ $286.88 Million	€67.74 Million ≈ $79.20 Million	0.276x	-15.64%
2011-12-31	€220.45 Million ≈ $257.73 Million	€72.15 Million ≈ $84.35 Million	0.327x	+61.69%
2010-12-31	€208.12 Million ≈ $243.32 Million	€42.13 Million ≈ $49.25 Million	0.202x	+0.63%
2009-12-31	€196.35 Million ≈ $229.56 Million	€39.50 Million ≈ $46.17 Million	0.201x	+34.53%
2008-12-31	€185.53 Million ≈ $216.90 Million	€27.74 Million ≈ $32.43 Million	0.150x	-1.67%
2007-12-31	€178.22 Million ≈ $208.36 Million	€27.10 Million ≈ $31.68 Million	0.152x	-17.89%
2006-12-31	€94.88 Million ≈ $110.93 Million	€17.57 Million ≈ $20.54 Million	0.185x	-55.57%
2005-12-31	€82.87 Million ≈ $96.88 Million	€34.54 Million ≈ $40.38 Million	0.417x	+372.91%
2004-12-31	€102.54 Million ≈ $119.88 Million	€9.04 Million ≈ $10.57 Million	0.088x	--

About Fagron NV

BR:FAGR Belgium Drug Manufacturers - Specialty & Generic

Market Cap

$2.04 Billion

€1.74 Billion EUR

Market Cap Rank

#6417 Global

#33 in Belgium

Share Price

€23.75

Change (1 day)

+1.50%

52-Week Range

€19.58 - €25.25

All Time High

€25.25